Atlas Trials

Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes

Clinical trial NCT04782999 · COMPLETED

Trial details

NCT number
NCT04782999
Sponsor
Hvidovre University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type2 DiabetesObesity, Morbid
Start date
2015-01-01
Primary completion
2022-01-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.